News In Brief
This article was originally published in The Gray Sheet
Executive Summary
ReGen seeks bankruptcy protection
You may also be interested in...
People In Brief
Spectranetics CEO
People In Brief
Spectranetics CEO
ReGen Declines "Futile" 510(k) Rescission Hearing But Plans Legal Challenge
ReGen Biologics says it is considering several last-ditch options to keep its collagen meniscus scaffold device on the U.S. market, but they do not include another hearing with FDA.